Halozyme Therapeutics News

Those Who Invested in Halozyme Therapeutics (NASDAQ:HALO) Five Years Ago Are up 159%

Simply Wall StDec 20 18:57

HC Wainwright & Co. Reiterates Buy on Halozyme Therapeutics, Maintains $68 Price Target

BenzingaDec 18 19:16 · Ratings

Johnson & Johnson Says Injectable Rybrevant Rejected by FDA

Seeking AlphaDec 17 19:48

How Much Upside Is Left in Halozyme Therapeutics (HALO)? Wall Street Analysts Think 27.08%

Yahoo FinanceDec 16 22:55

If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This Is How Much It'd Be Worth Now

Zacks Dec 16 20:35

(HALO) - Analyzing Halozyme Therapeutics's Short Interest

BenzingaDec 12 02:45

Editas Stock Rises on Updated Data From SCD Study of Reni-Cel

Zacks Dec 10 23:30

KOD Stock Up as Jefferies Upgrades Rating on Huge Pipeline Potential

Zacks Dec 10 23:00

Here Is Why Growth Investors Should Buy Halozyme Therapeutics (HALO) Now

Zacks Dec 6 00:55

Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%

Seeking AlphaNov 28 01:16

Halozyme to Present at Upcoming Investor Conferences

PR NewswireNov 27 21:30

HALO Withdraws Acquisition Bid for EVO, Reaffirms '24 View, Stock Up

Zacks Nov 25 23:00

Halozyme Therapeutics Price Target Maintained With a $68.00/Share by HC Wainwright & Co.

Dow JonesNov 25 20:28 · Ratings

Evotec Refutes Halozyme Therapeutics' Reason for Buyout Bid Withdrawal

MT NewswiresNov 25 12:30

Halozyme Therapeutics (NASDAQ:HALO) Has A Rock Solid Balance Sheet

Simply Wall StNov 23 22:49

Trending: Halozyme Drops Bid for Evotec

Dow JonesNov 23 02:50

Halozyme Therapeutics (HALO) Upgraded to Buy: Here's Why

Zacks Nov 23 00:15

Evotec Confirms Review Of Halozyme's Withdrawn EUR 11.00/Share Proposal, Reiterates Confidence In Standalone Growth Strategy

BenzingaNov 23 00:03

Express News | U.S.-Listed Shares of Evotec Down 19.8% Premarket

BreakingsNov 22 22:14

Sector Update: Health Care Stocks Advance Premarket Friday

MT NewswiresNov 22 22:13